News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Epitopea Signs Licensing and Research Collaboration Agreement with MSD to Identify Tumour-Specific Antigens
Thursday, February 20, 2025Epitopea a company focused on developing accessible offtheshelf RNAbased cancer immunotherapies has entered into a licence and research collaboration agreement with MSD the tradename of Merck Co Inc Rahway NJ USA The collaboration aims to identify C...
Clarity granted US FDA Fast Track Designation for Cu-67 SAR-bisPSMA in treating metastatic castration-resistant prostate cancer.
Thursday, February 20, 2025Clarity Pharmaceuticalsa clinicalstage radiopharmaceutical company focused on developing advanced treatments for cancer has received Fast Track Designation FTD from the United States Food and Drug Administration FDA
NecstGen and Digi.Bio Collaborate to Improve Cell and Gene Therapy Testing
Wednesday, February 19, 2025NecstGen and DigiBio have formed a collaboration to enhance testing and development in Cell and Gene Therapy NecstGen a nonprofit CDMO and DigiBio a developer of labonachip technology aim to improve the understanding of modified cells which have the...
Alvotech and Teva’s U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea, Accepted
Wednesday, February 19, 2025Alvotech a global biotech company focused on developing and manufacturing biosimilar medicines and Teva Pharmaceuticals have announced that the US Food and Drug Administration FDA has accepted a Biologics License Application
Cellistic introduces Allo Chassis™: Ready-to-use immune-shielded iPSC cell lines for affordable cell therapy development
Tuesday, February 18, 2025Cellistic a specialist in iPSCbased offtheshelf cell therapy development and manufacturing has introduced Allo Chassisreadytouse immuneshielded iPSC cell lines derived from CD and CD Tcell primary cells
Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
Friday, February 14, 2025Evolus Inc a performance beauty company with a focus on building an aesthetic portfolio today announced that the US Food and Drug Administration FDA has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Friday, February 14, 2025Conduit Pharmaceuticals Inc is pleased to announce an agreement with Charles River Laboratories Inc Charles River to evaluate AZD and its derivatives in a clinically relevant Systemic Lupus Erythematosus model This collaboration highlights
Illuccix® Approved in the United Kingdom
Thursday, February 13, 2025Telix Pharmaceuticals Limited announces that the United Kingdom UK Medicines and Healthcare Products Regulatory Agency MHRA has approved the Marketing Authorization Application MAA for its prostate cancer PET imaging agent Illuccix
BioCryst Launches ORLADEYO® (berotralstat) in Portugal
Thursday, February 13, 2025BioCryst Pharmaceuticals Inc announced that Infarmed in Portugal has recommended ORLADEYO berotralstat for the routine prevention of recurrent attacks of hereditary angioedema HAE in eligible patients years and older With this recommendation HAE pat...
Alloy Therapeutics partners with Pfizer in a long-term collaboration to develop a new antibody discovery platform.
Wednesday, February 12, 2025Alloy Therapeutics a biotechnology company focused on making advanced drug discovery technologies more accessible has announced a new partnership with Pfizer The collaboration aims to develop a platform that will improve Pfizers ability to identify e...
